Calicut Medicare And Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 9.65 Cr
as on 24-10-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 24-10-2024
- Revenue -19.97%
(FY 2023)
- Profit -31.94%
(FY 2023)
- Ebitda 38.43%
(FY 2023)
- Net Worth 0.48%
(FY 2023)
- Total Assets 8.87%
(FY 2023)
About Calicut Medicare And Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.65 Cr.
The company currently has active open charges totaling ₹2.50 M.
Kunhikammu Haji, Kupparayil Sanfir, Aboobacker, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U24232KL2009PTC024799
- Company No.
024799
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2009
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Calicut Medicare And Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abdul Gafoor  | Managing Director | 25-Sep-2009 | Current |
Board Members(11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunhikammu Haji | Director | 27-Jun-2022 | Current |
| Kupparayil Sanfir | Director | 14-Sep-2017 | Current |
| Aboobacker | Director | 25-Sep-2009 | Current |
| Ishak Veedu | Director | 14-Jan-2010 | Current |
| Hafis Hassan | Director | 14-Jan-2010 | Current |
| Abdul Kandy | Director | 14-Jan-2010 | Current |
Financial Performance of Calicut Medicare And Pharma.
Calicut Medicare And Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.97% decrease. The company also saw a substantial fall in profitability, with a 31.94% decrease in profit. The company's net worth moved up by a moderate rise of 0.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Calicut Medicare And Pharma?
In 2023, Calicut Medicare And Pharma had a promoter holding of 50.26% and a public holding of 49.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kayakkodi Sand And Granite Private LimitedActive 11 years 2 months
Kunhikammu Haji is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Apr 2022 | ₹2.50 M | Open |
How Many Employees Work at Calicut Medicare And Pharma?
Unlock and access historical data on people associated with Calicut Medicare And Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calicut Medicare And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calicut Medicare And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
